It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Predicting the pathogenicity of biallelic missense variants can be challenging. Here, we use a deficit of observed homozygous carriers of missense variants, versus an expected number in a set of 153,054 chip-genotyped Icelanders, to identify potentially pathogenic genotypes. We follow three missense variants with a complete deficit of homozygosity and find that their pathogenic effect in homozygous state ranges from severe childhood disease to early embryonic lethality. One of these variants is in CPSF3, a gene not previously linked to disease. From a set of clinically sequenced Icelanders, and by sequencing archival samples targeted through the Icelandic genealogy, we find four homozygous carriers. Additionally, we find two homozygous carriers of Mexican descent of another missense variant in CPSF3. All six homozygous carriers of missense variants in CPSF3 show severe intellectual disability, seizures, microcephaly, and abnormal muscle tone. Here, we show how the absence of certain homozygous genotypes from a large population set can elucidate causes of previously unexplained recessive diseases and early miscarriage.
While the consequences of homozygous loss of function variants have been studied, the effect of missense variants is less understood. Here, the authors identify pathogenic genotypes through an observed deficit of homozygous carriers of missense variants in a population, elucidating previously unexplained recessive disease and miscarriage.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details











1 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.421812.c) (ISNI:0000 0004 0618 6889); University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)
2 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.421812.c) (ISNI:0000 0004 0618 6889)
3 The National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
4 Children’s Hospital of Orange County, Division of Metabolic Disorders, Orange, USA (GRID:grid.414164.2) (ISNI:0000 0004 0442 4003)
5 The National University Hospital of Iceland, Department of Pathology, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
6 The National University Hospital of Iceland, Children’s Hospital Iceland, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
7 University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); The National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
8 University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); The National University Hospital of Iceland, Department of Pathology, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842)
9 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.421812.c) (ISNI:0000 0004 0618 6889); University of Iceland, School of Engineering and Natural Sciences, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021)
10 University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); The National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842); Johns Hopkins University, Department of Genetic Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311)